1. Home
  2. CUE vs PROV Comparison

CUE vs PROV Comparison

Compare CUE & PROV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cue Biopharma Inc.

CUE

Cue Biopharma Inc.

HOLD

Current Price

$31.26

Market Cap

124.5M

Sector

Health Care

ML Signal

HOLD

Logo Provident Financial Holdings Inc.

PROV

Provident Financial Holdings Inc.

HOLD

Current Price

$17.25

Market Cap

107.4M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
CUE
PROV
Founded
2014
1956
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Savings Institutions
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
124.5M
107.4M
IPO Year
2017
2009

Fundamental Metrics

Financial Performance
Metric
CUE
PROV
Price
$31.26
$17.25
Analyst Decision
Strong Buy
Hold
Analyst Count
1
2
Target Price
$120.00
$16.25
AVG Volume (30 Days)
115.0K
3.4K
Earning Date
05-13-2026
04-28-2026
Dividend Yield
N/A
3.26%
EPS Growth
61.11
N/A
EPS
N/A
0.68
Revenue
$27,466,000.00
N/A
Revenue This Year
N/A
$4.14
Revenue Next Year
N/A
$3.70
P/E Ratio
N/A
$25.31
Revenue Growth
195.75
N/A
52 Week Low
$0.17
$14.95
52 Week High
$45.50
$17.42

Technical Indicators

Market Signals
Indicator
CUE
PROV
Relative Strength Index (RSI) 53.29 57.60
Support Level $23.88 $16.95
Resistance Level $32.82 $17.38
Average True Range (ATR) 4.68 0.15
MACD -0.52 0.00
Stochastic Oscillator 26.82 58.82

Price Performance

Historical Comparison
CUE
PROV

About CUE Cue Biopharma Inc.

Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune diseases with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103, and others.

About PROV Provident Financial Holdings Inc.

Provident Financial Holdings Inc is a holding company of Provident Savings Bank, F.S.B. It is a financial services company committed to serving consumers and small to mid-sized businesses in the Inland Empire region of Southern California. Its business activities consist of community banking, investment services and trustee services for real estate transactions. The group operates in Bank segment that include attracting deposits, offering banking services and originating and purchasing single-family, multi-family, commercial real estate, construction and, to a lesser extent, other mortgage, commercial business and consumer loans. Its evenues are derived from interest earned on its loan and investment portfolios, and fees generated through its community banking activities.

Share on Social Networks: